Macrophage barrier in the tumor microenvironment and potential clinical applications DOI Creative Commons
Shuai Ji, Yuqing Shi, Bo Yin

и другие.

Cell Communication and Signaling, Год журнала: 2024, Номер 22(1)

Опубликована: Янв. 26, 2024

Abstract The tumor microenvironment (TME) constitutes a complex comprising diverse array of immune cells and stromal components. Within this intricate context, tumor-associated macrophages (TAMs) exhibit notable spatial heterogeneity. This heterogeneity contributes to various facets behavior, including response modulation, angiogenesis, tissue remodeling, metastatic potential. review summarizes the distribution in both physiological environment TME. Moreover, paper explores interactions between TAMs cell populations (T cells, dendritic neutrophils, natural killer other cells) within These bidirectional exchanges form network that influence surveillance evasion strategies. Investigating TAM its with different offers potential avenues for therapeutic interventions. Additionally, discusses strategies targeting macrophages, aiming uncover novel approaches immunotherapy.

Язык: Английский

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth DOI Creative Commons
Karin E. de Visser, Johanna A. Joyce

Cancer Cell, Год журнала: 2023, Номер 41(3), С. 374 - 403

Опубликована: Март 1, 2023

Язык: Английский

Процитировано

1722

The cancer-immunity cycle: Indication, genotype, and immunotype DOI Creative Commons
Ira Mellman, Daniel S. Chen, Thomas Powles

и другие.

Immunity, Год журнала: 2023, Номер 56(10), С. 2188 - 2205

Опубликована: Окт. 1, 2023

The cancer-immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. It emphasizes iterative nature response where killing tumor cells by T initiates subsequent rounds antigen presentation and cell stimulation, maintaining active immunity adapting it evolution. Any step can become rate-limiting, rendering system unable control growth. Here, we update based on remarkable progress past decade. Understanding mechanism checkpoint inhibition has evolved, as our view dendritic in sustaining anti-tumor immunity. We additionally account for role microenvironment facilitating, not just suppressing, response, discuss importance considering tumor's immunological phenotype, "immunotype". While these new insights add some complexity cycle, they also provide targets research therapeutic intervention.

Язык: Английский

Процитировано

393

CD8+ T cells in the cancer-immunity cycle DOI Creative Commons
Josephine R. Giles, Anna-Maria Globig,

Susan M. Kaech

и другие.

Immunity, Год журнала: 2023, Номер 56(10), С. 2231 - 2253

Опубликована: Окт. 1, 2023

Язык: Английский

Процитировано

177

Roles of macrophages in tumor development: a spatiotemporal perspective DOI Creative Commons

Mathilde Bied,

William W. Ho, Florent Ginhoux

и другие.

Cellular and Molecular Immunology, Год журнала: 2023, Номер 20(9), С. 983 - 992

Опубликована: Июль 10, 2023

Abstract Macrophages are critical regulators of tissue homeostasis but also abundant in the tumor microenvironment (TME). In both primary tumors and metastases, such tumor-associated macrophages (TAMs) seem to support development. While we know that TAMs dominant immune cells TME, their vast heterogeneity associated functions only just being unraveled. this review, outline various known TAM populations found thus far delineate specialized roles with main stages cancer progression. We discuss how may prime premetastatic niche enable growth a metastasis then subsequent metastasis-associated can secondary growth. Finally, speculate on challenges remain be overcome research.

Язык: Английский

Процитировано

148

Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer DOI Creative Commons
Briana G. Nixon, Fengshen Kuo, Liangliang Ji

и другие.

Immunity, Год журнала: 2022, Номер 55(11), С. 2044 - 2058.e5

Опубликована: Окт. 25, 2022

Язык: Английский

Процитировано

122

Radiation-induced tumor immune microenvironments and potential targets for combination therapy DOI Creative Commons
Siyu Guo, Yihan Yao,

Yang Tang

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Май 19, 2023

As one of the four major means cancer treatment including surgery, radiotherapy (RT), chemotherapy, immunotherapy, RT can be applied to various cancers as both a radical and an adjuvant before or after surgery. Although is important modality for treatment, consequential changes caused by in tumor microenvironment (TME) have not yet been fully elucidated. RT-induced damage cells leads different outcomes, such survival, senescence, death. During RT, alterations signaling pathways result local immune microenvironment. However, some are immunosuppressive transform into phenotypes under specific conditions, leading development radioresistance. Patients who radioresistant respond poorly may experience progression. Given that emergence radioresistance inevitable, new radiosensitization treatments urgently needed. In this review, we discuss irradiated TME regimens describe existing potential molecules could targeted improve therapeutic effects RT. Overall, review highlights possibilities synergistic therapy building on research.

Язык: Английский

Процитировано

82

Stem-like exhausted and memory CD8+ T cells in cancer DOI
Thomas Gebhardt, Simone L. Park, Ian A. Parish

и другие.

Nature reviews. Cancer, Год журнала: 2023, Номер 23(11), С. 780 - 798

Опубликована: Окт. 11, 2023

Язык: Английский

Процитировано

78

Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment DOI
Kevin M. Tharp, Kelly Kersten, Ori Maller

и другие.

Nature Cancer, Год журнала: 2024, Номер 5(7), С. 1045 - 1062

Опубликована: Июнь 3, 2024

Язык: Английский

Процитировано

72

Localization, tissue biology and T cell state — implications for cancer immunotherapy DOI
Jason M. Schenkel, Kristen E. Pauken

Nature reviews. Immunology, Год журнала: 2023, Номер 23(12), С. 807 - 823

Опубликована: Май 30, 2023

Язык: Английский

Процитировано

68

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors DOI Creative Commons
Michael Kilian, Ron Sheinin, Chin Leng Tan

и другие.

Cancer Cell, Год журнала: 2023, Номер 41(2), С. 235 - 251.e9

Опубликована: Янв. 12, 2023

Язык: Английский

Процитировано

66